Wuhan Keqian Biology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 7.36% vs -15.44% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -1.99% vs -31.54% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "227.50",
          "val2": "211.90",
          "chgp": "7.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "67.90",
          "val2": "80.70",
          "chgp": "-15.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.40",
          "val2": "5.70",
          "chgp": "-57.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "78.70",
          "val2": "80.30",
          "chgp": "-1.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "298.30%",
          "val2": "245.90%",
          "chgp": "5.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.81% vs -11.23% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.28% vs -3.56% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "946.10",
          "val2": "938.50",
          "chgp": "0.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "479.50",
          "val2": "417.50",
          "chgp": "14.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "5.00",
          "chgp": "-96.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "32.00",
          "val2": "27.30",
          "chgp": "17.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "416.90",
          "val2": "381.50",
          "chgp": "9.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "386.70%",
          "val2": "327.90%",
          "chgp": "5.88%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

227.50

211.90

7.36%

Operating Profit (PBDIT) excl Other Income

67.90

80.70

-15.86%

Interest

0.10

0.00

Exceptional Items

2.40

5.70

-57.89%

Consolidate Net Profit

78.70

80.30

-1.99%

Operating Profit Margin (Excl OI)

298.30%

245.90%

5.24%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 7.36% vs -15.44% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -1.99% vs -31.54% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

946.10

938.50

0.81%

Operating Profit (PBDIT) excl Other Income

479.50

417.50

14.85%

Interest

0.20

5.00

-96.00%

Exceptional Items

32.00

27.30

17.22%

Consolidate Net Profit

416.90

381.50

9.28%

Operating Profit Margin (Excl OI)

386.70%

327.90%

5.88%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.81% vs -11.23% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.28% vs -3.56% in Dec 2024

All Annual Results